Indium-111-Pentetreotide Scintigraphy in Children with Neuroblast-Derived Tumors

Journal of Nuclear Medicine

Volumn 37, Issue 6, 1996, Pages 893-896

  Manil, Luc ^a   Edeline, Véronique ^b   Lumbroso, Jean ^b   Lequen, Hélène ^b   Zucker, Jean Michel ^b  

^a Nuclear Medicine   (France)

^b NONE

Author keywords

Ganglioneuroblastoma; Indium 111 pentetreotide; Iodine 131 MIBG; Neuroblastoma; Pediatrics

Indexed keywords

(3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDIUM; IODOBENZENE; PENTETREOTIDE; RADIOACTIVE IODINE; SOMATOSTATIN;

ABDOMINAL TUMOR; ADRENAL TUMOR; ARTICLE; BONE MARROW CANCER; CHILD; COMPARATIVE STUDY; FEMALE; GANGLIONEUROMA; HUMAN; INFANT; MALE; MEDIASTINUM TUMOR; METASTASIS; NEUROBLASTOMA; PRESCHOOL CHILD; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; ABDOMINAL NEOPLASMS; ADRENAL GLAND NEOPLASMS; BONE MARROW NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GANGLIONEUROBLASTOMA; GANGLIONEUROMA; HUMANS; INDIUM RADIOISOTOPES; INFANT; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MEDIASTINAL NEOPLASMS; NEUROBLASTOMA; SOMATOSTATIN;

EID: 0030160462     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. 123I-Tyr3)-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716 -731.
2. Krenning EP, Bakker WH, Breeman WA, et al. Localization of endocrine-related tumors with radioiodinated analog of somatostatin. Lancet 1989;1:242-244.
3. Lamberts SW, Bakker WH, Reubi JC, Krenning EP. Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med 1990;323:1246-1249.
4. Becker W, Marienhagen J, Scheubel R, et al. Octreotide scintigraphy localizes somatostatin receptor-positive islet cell carcinomas. Eur J Nucl Med 1991;18:924-927.
5. Kwekkenboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PP, Lamberts SW. Somatostatin analog scintigraphy in careinoid tumors. Eur J Nucl Med 1993;20:283-292.
6. Dörr U, Räth U, Sautter-Bihl ML, Guzman G, Bach D, Adrian HJ. Improved visualization of careinoid liver metastases by indium-111-pentetreotide scintigraphy following treatment with cold somatostatin analog. Eur J Nucl Med 1993;20:431-433.
7. Ur E, Mather SJ, Bomanji J, et al. Pituitary imaging using a labeled somatostatin analog in acromegaly. Clin Endocrinol 1992;36:147-150.
8. Kwekkeboom DJ, Krenning EP, Bakker WH, et al. Radioiodinated somatostatin analog scintigraphy in small-cell lung cancer. J Nucl Med 1991;32:1845-1848.
9. Oei HY, Krenning EP, Lamberts SW. Somatostatin receptor imaging using Octreoscan 111. Folder Mallinckrodt 1994.
10. Vanhagen PM, Krenning EP, Reubi JC, et al. Somatostatin analog scintigraphy of malignant lymphomas. Br J Haematol 1993;83:75-79.
11. McKinney M, Barrett RW. Biochemical evidence for somatostatin receptors in murine neuroblastoma clone N1E-115. Eur J Pharmacol 1989;162:397-405.
12. Qualman SJ, O'Dorisio MS, Fleshman DJ, Shimada H, O'Dorisio TM. Neuroblastoma. Correlation of neuropeptide expression in tumor tissue with other prognostic factors. Cancer 1992;70:2005-2012.
13. 111In-pentetreotide by an MIBG negative xenografted neuroblastoma. Int J Cancer 1994;57:245-246.
14. 111In-labeled octreotide (In-OCT) for tumor imaging. Initial results in neuroblastoma. EANM Congress. Lisboa, Portugal, 23-26 August 1992. Eur J Nucl Med 1992;19:737.
15. Dörr U, Sautter-Bihl ML, Schilling FH, Koscielniak E, Treuner J, Bihl H. Somatostatin receptor scintigraphy: a new diagnostic tool in neuroblastoma? Prog Clin Biol Res 1994;385:355-361.
16. Hoefnagel CA. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumors. Eur J Nucl Med 1994;21:561-581.
17. Hoefnagel CA, de Kraker J. Childhood neoplasia. In: Murray IPC, Ell PJ, eds. Nuclear medicine in clinical diagnosis and treatment. London: Churchill Livingstone 1995.
18. Lumbroso J, Guermazi F, Hartmann O, et al. Sensitivity and specificity of metaiodobenzylguanidine in the exploration of neuroblastoma: analysis of 115 scans. Bull Cancer (Paris) 1988;75:97-106.
19. Ady N, Zucker JM, Asselain B, et al. A new 1-231-MIBG whole body scan scoring method. Application to the prediction of the response of metastases to induction chemotherapy in Stage IV neuroblastoma. Eur J Cancer 1995;31A:256-261.